CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis

Published:2019-03-05 Issue:6 Volume:24 Page:649-659
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Zhang Hanfei,Cai Weiguo,Wang Yanfan,Liao Meiyan^ORCID,Tian Sufang

Funder

Key Foundation of Hubei Natural Science Funds

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-019-01403-3.pdf

Reference35 articles.

1. Ettinger DS, Akerley W, Borghaei H et al (2012) Non-small cell lung cancer. J Natl Compr Cancer Netw 10(10):1236–1271

2. Detterbeck FC, Boffa DJ, Tanoue LT (2009) The new lung cancer staging system. Chest 136(1):260–271

3. Goldstraw P, Chansky K, Crowley J et al (2016) The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 11(1):39–51

4. Buettner R, Wolf J, Thomas RK (2013) Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment. J Clin Oncol Off J Am Soc Clin Oncol 31(15):1858–1865

5. Abdallah SM, Hirsh V (2018) Irreversible tyrosine kinase inhibition of epidermal growth factor receptor with afatinib in EGFR activating mutation-positive advanced non-small-cell lung cancer. Curr Oncol 25(Suppl 1):S9–S17

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.;BMC Cancer;2024-03-25

2. Transfer learning–based PET/CT three-dimensional convolutional neural network fusion of image and clinical information for prediction of EGFR mutation in lung adenocarcinoma;BMC Medical Imaging;2024-03-04

3. Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma;Clinical and Translational Oncology;2024-01-09

4. The differential prognostic implications of PD-L1 expression in the outcomes of Filipinos with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors;Translational Lung Cancer Research;2023-09

5. EGFR Exon 20 Insertion Mutations: CT Characteristics and Clinicopathologic Features in Non-Small Cell Lung Cancer;2023-05-18